Ad Code: 26345

Patients with a hematologic malignancy, as well as those with benign hematologic conditions, are often immunocompromised, explains Mette D. Hazenberg, MD, PhD. “This can be related to the condition,” Dr. Hazenberg says. “For...

In patients with central nervous system (CNS) relapse of mantle cell lymphoma (MCL), ibrutinib was linked with superior survival compared with blood-brain barrier (BBB)-penetrating chemotherapy, according to a study published in...

For patients with multiple myeloma (MM), exercise interventions appear safe and well attended, according to a study published in Clinical Lymphoma, Myeloma & Leukemia. Jennifer L. Nicol and colleagues conducted a systematic...